Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 21, 2024, titled "CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK s MHRA".
Press Release Dec 21 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Dec 13 2024
- Press Release Dec 05 2024
- Annual CSR Report 2023-24
- Press Release Nov 12 2024
- Q2 UFR 2024 25 Corrigendum in Consolidated UFR
Later from Aurobindo Pharma
- Press Release Jan 31 2025
- Press Release Feb 06 2025
- Press Release Apr 09 2025
- Press Release Apr 12 2025
- Press Release Apr 23 2025
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma